EPIGLOTTIC CANCER

This adverse event was reported 32 times

These drugs are most commonly taken by patients reporting EPIGLOTTIC CANCER:

# Drug Count
0 RANITIDINE HYDROCHLORIDE 4
1 RANITIDINE 2
2 USTEKINUMAB 2
3 ADALIMUMAB-ADAZ 1
4 AMLODIPINE 1
5 BEVACIZUMAB 1
6 FARICIMAB 1
7 FORMOTEROL FUMARATE 1
8 FORMOTEROL FUMARATE DIHYDRATE 1
9 GLATIRAMER ACETATE 1
See all common drugs associated with EPIGLOTTIC CANCER

EPIGLOTTIC CANCER is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IVABRADINE 1 0.0001
1 FARICIMAB 1 0.0001
2 RANITIDINE HYDROCHLORIDE 4 0.0001
3 RANIBIZUMAB 1 0.0000
4 USTEKINUMAB 2 0.0000
5 ADALIMUMAB-ADAZ 1 0.0000
6 GLATIRAMER ACETATE 1 0.0000
7 SULFASALAZINE 1 0.0000
8 LOSARTAN POTASSIUM 1 0.0000
9 RANITIDINE 2 0.0000
See all drugs enriched for association with EPIGLOTTIC CANCER